David Garman

Efficacy and safety of nerinetide for the treatment of acute ischaemic stroke (ESCAPE-NA1): a multicentre, double-blind, randomised controlled trial

Michael D. Hill, Mayank Goyal, Bijoy K. Menon et al. · The Lancet · 2020 · 601 citations · Full text

Safety and efficacy of NA-1 in patients with iatrogenic stroke after endovascular aneurysm repair (ENACT): a phase 2, randomised, double-blind, placebo-controlled trial

Michael D. Hill, Renee Martin, David J. Mikulis et al. · The Lancet Neurology · 2012 · 396 citations

Thrombosis, Endovascular Technique, Cardiovascular Disease +12

College Selectivity and Earnings

Linda Datcher Loury, David Garman · Journal of Labor Economics · 1995 · 342 citations

Educational Attainment, Social Sciences, African American Studies +17

PDZ Protein Interactions Underlying NMDA Receptor-Mediated Excitotoxicity and Neuroprotection by PSD-95 Inhibitors

Hong Cui, Amy Hayashi, Hong‐Shuo Sun et al. · Journal of Neuroscience · 2007 · 207 citations · Full text

Efficacy and safety of nerinetide in acute ischaemic stroke in patients undergoing endovascular thrombectomy without previous thrombolysis (ESCAPE-NEXT): a multicentre, double-blind, randomised controlled trial

Michael D. Hill, Mayank Goyal, Andrew M. Demchuk et al. · The Lancet · 2025 · 37 citations · Full text